A Review of The Performance of Artificial Intelligence In The Analysis of Chest CTs For The Diagnosis of COVID-19
DOI:
https://doi.org/10.32553/jbpr.v11i6.823Keywords:
Antimicrobial resistance, Emergency department, Clinical pharmacistsAbstract
During the COVID-19 pandemic, chest CTs was used as an alternative for diagnosis of COVID-19. This resulted in the use of artificial intelligence as an independent assessor and in aiding the radiologist in the diagnosis of COVID-19. In this short review, we assessed the accuracy, sensitivity and specificity of AI software employed. The average accuracy, sensitivity and specificity were found to be 94.38%, 91.64% and 91.10% respectively. Despite the limitations of AI, it proved to be a valuable and reliable tool in diagnosis of COVID-19
Downloads
Published
How to Cite
Issue
Section
License
Journal of Biomedical and Pharmaceutical Research by Articles is licensed under a Creative Commons Attribution 4.0 International License.
